- Home
- SEER
SEER
Seer Inc.
as 02-21-2025 4:00pm EST
Seer Inc is a biotechnology company. The company commercializes transformative products for researchers to unlock deep, unbiased biological information. Its product, the Proteograph Product Suite (Proteograph), will leverage its proprietary engineered nanoparticle (NP) technology to provide unbiased, deep, rapid, and large-scale access across the proteome.
Upcoming Earnings Alert:
Get ready for potential market movements as Seer Inc. SEER prepares to release earnings report on 27 Feb 2025.
| Founded: | 2017 | Country: | United States |
| Employees: | N/A | City: | REDWOOD CITY |
| Market Cap: | 136.2M | IPO Year: | 2020 |
| Target Price: | $3.00 | AVG Volume (30 days): | 204.9K |
| Analyst Decision: | Hold | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.30 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.53 - $2.63 | Next Earning Date: | 02-27-2025 |
| Revenue: | $14,608,000 | Revenue Growth: | -13.19% |
| Revenue Growth (this year): | -13.56% | Revenue Growth (next year): | 34.78% |
Stock Insider Trading Activity of Seer Inc. (SEER)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Farokhzad Omid | SEER | CEO AND CHAIR | Feb 4 '25 | Sell | $2.24 | 8,068 | $18,044.08 | 1,428,217 | |
| Horn David R. | SEER | PRESIDENT & CFO | Feb 4 '25 | Sell | $2.24 | 3,550 | $7,939.58 | 476,961 |
Latest Seer Inc. News
SEER Breaking Stock News: Dive into SEER Ticker-Specific Updates for Smart Investing
GlobeNewswire
a day ago
Seer to Participate in the TD Cowen 45th Annual Health Care Conference
Simply Wall St.
2 days ago
US Penny Stocks: 3 Picks With Market Caps As Low As $70M
GlobeNewswire
2 days ago
Seer to Feature Proteomic Advancements in Cancer and RNA Therapy Research among other Findings at US HUPO 2025
GlobeNewswire
9 days ago
Seer to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025
GlobeNewswire
2 months ago
Seer to Present at the J.P. Morgan 43rd Annual Healthcare Conference
Simply Wall St.
2 months ago
Spotlight On US Penny Stocks For January 2025
Simply Wall St.
2 months ago
Seer (NASDAQ:SEER) Is In A Good Position To Deliver On Growth Plans
GlobeNewswire
3 months ago
Seer Ranked Number 57 Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500™
Compare SEER vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "SEER Seer Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.